Lovastatin suppresses the aberrant tau phosphorylation from FTDP-17 mutation and okadaic acid-induction in rat primary neurons

Neuroscience

Volumn 294, Issue , 2015, Pages 14-20

  Li, R ^a   Xu, D E ^a   Ma, T ^a  

^a WUXI NO 2 PEOPLE S HOSPITAL   (China)

Author keywords

Alzheimer's disease; CDK; Lovastatin; Okadaic acid; PP2A; Tau phosphorylation

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; MEVINOLIN; MUTANT PROTEIN; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2A; SERINE; TAU PROTEIN; TYROSINE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CHROMOSOME 17; CHROMOSOME MUTATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; FRONTOTEMPORAL DEMENTIA; NERVE CELL; NEUROPROTECTION; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; ANIMAL; CELL CULTURE; DRUG EFFECTS; GENETICS; METABOLISM; MUTATION; PHOSPHORYLATION; SPRAGUE DAWLEY RAT;

ALZHEIMER DISEASE; ANIMALS; CELLS, CULTURED; FRONTOTEMPORAL DEMENTIA; LOVASTATIN; MUTATION; NEURONS; OKADAIC ACID; PHOSPHORYLATION; RATS, SPRAGUE-DAWLEY; TAU PROTEINS;

EID: 84925374347     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.03.005     Document Type: Article

References (39)

1. Boimel M., Grigoriadis N., Lourbopoulos A., Touloumi O., Rosenmann D., Abramsky O., Rosenmann H. Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy. J Neuropathol Exp Neurol 2009, 68:314-325.
2. Burns M., Duff K. Cholesterol in Alzheimer's disease and tauopathy. Ann N Y Acad Sci 2002, 977:367-375.
3. Chen M., Fernandez H.L. Where do Alzheimer's plaques and tangles come from? Aging-induced protein degradation inefficiency. Front Biosci 2001, 6:E1-E11.
4. Di Paolo G., Kim T.W. Linking lipids to Alzheimer's disease: cholesterol and beyond. Nat Rev Neurosci 2011, 12:284-296.
5. Fan Q.W., Yu W., Senda T., Yanagisawa K., Michikawa M. Cholesterol-dependent modulation of tau phosphorylation in cultured neurons. J Neurochem 2001, 76:391-400.
6. Gong C.X., Liu F., Grundke-Iqbal I., Iqbal K. Dysregulation of protein phosphorylation/dephosphorylation in Alzheimer's disease: a therapeutic target. J Biomed Biotechnol 2006, 2006:31825-31835.
7. Gong C.X., Singh T.J., Grundke-Iqbal I., Iqbal K. Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 1993, 61:921-927.
8. Hernández M.L., Martínez M.J., López de Heredia M., Ochoa B. Protein phosphatase 1 and 2A inhibitors activate acyl-CoA: cholesterol acyltransferase and cholesterol ester formation in isolated rat hepatocytes. Biochim Biophys Acta 1997, 1349:233-241.
9. Ho D.T., Shayan H., Murphy T.H. Okadaic acid induces hyperphosphorylation of tau independently of mitogen-activated protein kinase activation. J Neurochem 1997, 68:106-111.
10. Höglund K., Blennow K. Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease. CNS Drugs 2007, 21:449-462.
11. Hughes K., Nikolakaki E., Plyte S.E., Totty N.F., Woodgett J.R. Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J 1993, 12:803-808.
12. Lee M.S., Kwon Y.T., Li M., Peng J., Friedlander R.M., Tsai L.H. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 2000, 405:360-364.
13. Lee V.M., Goedert M., Trojanowski J.Q. Neurodegenerative tauopathies. Annu Rev Neurosci 2001, 24:1121-1159.
14. Lim Y.W., Yoon S.Y., Choi J.E., Kim S.M., Lee H.S., Choe H., et al. Maintained activity of glycogen synthase kinase-3beta despite of its phosphorylation at serine-9 in okadaic acid-induced neurodegenerative model. Biochem Biophys Res Commun 2010, 395:207-212.
15. Liu F., Grundke-Iqbal I., Iqbal K., Gong C.X. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neurosci 2005, 22:1942-1950.
16. Lu F., Li X., Suo A.Q., Zhang J.W. Inhibition of tau hyperphosphorylation and beta amyloid production in rat brain by oral administration of atorvastatin. Chin Med J 2010, 123:1864-1870.
17. Ma T., Zhao Y., Kwak Y.D., Yang Z., Thompson R., Luo Z., et al. Statin's excitoprotection is mediated by sAPP and the subsequent attenuation of calpain-induced truncation events, likely via rho-ROCK signaling. J Neurosci 2009, 29:11226-11236.
18. McGuinness B., O'Hare J., Craig D., Bullock R., Malouf R., Passmore P. Statins for the treatment of dementia. Cochrane Database Syst Rev 2010, 7. CD007514.
19. Montagnoli A., Fiore F., Eytan E., Carrano A.C., Draetta G.F., Hershko A. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev 1999, 13:1181-1189.
20. Ostrowski S.M., Wilkinson B.L., Golde T.E., Landreth G. Statins reduce amyloid-beta production through inhibition of protein isoprenylation. J Biol Chem 2007, 282:26832-26844.
21. Parsons R.B., Farrant J.K., Price G.C., Subramaniam D., Austen B.M. Regulation of the lipidation of beta-secretase by statins. Biochem Soc Trans 2007, 35:577-582.
22. Pei J.J., Tanaka T., Tung Y.C., Braak E., Iqbal K., Grundke-Iqbal I. Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol 1997, 56:70-78.
23. Pérez M., Lim F., Arrasate M., Avila J. The FTDP-17-linked mutation R406W abolishes the interaction of phosphorylated tau with microtubules. J Neurochem 2000, 74:2583-2589.
24. Poon R.Y., Toyoshima H., Hunter T. Redistribution of the CDK inhibitor p27 between different cyclin. CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol Biol Cell 1995, 6:1197-1213.
25. Postina R. Activation of α-secretase cleavage. J Neurochem 2012, 120:46-54.
26. Qian W., Shi J., Yin X., Iqbal K., Grundke-Iqbal I., Gong C.X., et al. PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta. J Alzheimers Dis 2010, 19:1221-1229.
27. Rao S., Lowe M., Herliczek T.W., Keyomarsi K. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53. Oncogene 1998, 17:2393-2402.
28. Rao S., Porter D.C., Chen X., Herliczek T., Lowe M., Keyomarsi K. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proc Natl Acad Sci U S A 1999, 96:7797-7802.
29. Roy A., Pahan K. Prospects of statins in Parkinson disease. Neuroscientist 2011, 17:244-255.
30. Shepardson N.E., Shankar G.M., Selkoe D.J. Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies. Arch Neurol 2011, 68:1239-1244.
31. Solomon A., Kivipelto M., Wolozin B., Zhou J., Whitmer R.A. Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr Cogn Disord 2009, 28:75-80.
32. Van der Most P.J., Dolga A.M., Nijholt I.M., Luiten P.G., Eisel U.L. Statins: mechanisms of neuroprotection. Prog Neurobiol 2009, 88:64-75.
33. Vogelsberg-Ragaglia V., Bruce J., Richter-Landsberg C., Zhang B., Hong M., Trojanowski J.Q., et al. Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. Mol Biol Cell 2000, 11:4093-4104.
34. Wang J.Z., Xia Y.Y., Grundke-Iqbal I., Iqbal K. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. J Alzheimers Dis 2013, 33:S123-S139.
35. Wang Q., Yan J., Chen X., Li J., Yang Y., Weng J., et al. Statins: multiple neuroprotective mechanisms in neurodegenerative diseases. Exp Neurol 2011, 230:27-34.
36. Wolozin B. Cholesterol and Alzheimer's disease. Biochem Soc Trans 2002, 30:525-529.
37. Wolozin B., Manger J., Bryant R., Cordy J., Green R.C., McKee A. Re-assessing the relationship between cholesterol, statins and Alzheimer's disease. Acta Neurol Scand 2006, 114:63-70.
38. Yoon S., Choi J., Huh J.W., Hwang O., Kim D. Calpain activation in okadaic-acid-induced neurodegeneration. Neuroreport 2006, 17:689-692.
39. Zhang Z., Simpkins J.W. Okadaic acid induces tau phosphorylation in SH-SY5Y cells in an estrogen-preventable manner. Brain Res 2010, 1345:176-181.